Filing Details

Accession Number:
0001209191-16-150867
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-17 16:29:54
Reporting Period:
2016-11-15
Filing Date:
2016-11-17
Accepted Time:
2016-11-17 16:29:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236934 J Paula Swain 1801 Augustine Cut-Off
Wilmington DE 19803
Evp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-15 7,683 $14.72 36,931 No 4 M Direct
Common Stock Acquisiton 2016-11-15 2,317 $14.72 39,248 No 4 M Direct
Common Stock Disposition 2016-11-15 10,000 $103.26 29,248 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2016-11-15 7,683 $0.00 7,683 $14.72
Common Stock Non-Qualified Stock Option (right to buy Disposition 2016-11-15 2,317 $0.00 2,317 $14.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-01-24 No 4 M Direct
0 2018-01-24 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Represents weighted average sale price. Actual sale prices ranged from $101.77- $104.60.
  3. Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  4. Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  5. Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.